You have 9 free searches left this month | for more free features.

Condition

Leukemia, Myeloid (2)

Leukemia (1)

Myelodysplastic Syndromes (1)

Overall Status

Completed (3)

Sign in for free

Phase

phase 1/phase 2 (2)

phase 3 (1)

Sponsor

Kanisa Pharmaceuticals (2)

Eastern Cooperative Oncology Group (1)

Collaborator

Eli Lilly and Company (1)

Kanisa Pharmaceuticals (1)

National Cancer Institute (NCI) (1)

Intervention

cytarabine (2)

zosuquidar (2)

daunorubicin (1)

daunorubicin hydrochloride (1)

filgrastim (1)

gemtuzumab ozogamicin (1)

placebo (1)

sargramostim (1)

zosuquidar trihydrochloride (1)

Study Documents

Intervention Type

drug (3)

biological (1)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

Zosuquidar

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Leukemia, MDS Trial in Israel, United States (filgrastim, sargramostim, cytarabine)

Completed

Has Results

Leukemia
Myelodysplastic Syndromes

filgrastim
+5 more

Scottsdale, Arizona
+91 more

Jun 1, 2015

Leukemia, Myeloid Trial (Zosuquidar, gemtuzumab ozogamicin)

Completed

Leukemia, Myeloid

Zosuquidar
gemtuzumab ozogamicin

(no location specified)

Mar 28, 2008

Leukemia, Myeloid Trial (Zosuquidar, Daunorubicin, Cytarabine)

Completed

Leukemia, Myeloid

Zosuquidar
+2 more

(no location specified)

Mar 28, 2008